Lineage Cell Therapeutics Revenue, Growth & Competitor Profile

DBA BIOTIME INC

Company Profile & Annual Report for Lineage Cell Therapeutics

Access the complete profile.

Lineage Cell Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5411 Legal Services
Additional NAICS Codes	325414 Biological Product Manufacturing 5417 Scientific Research & Development Services
Address	2173 Salk Ave Ste 200 Carlsbad, CA 92008

Lineage Cell Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Lineage Cell Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Lineage Cell Therapeutics is classified as operating in the Legal Services industry, NAICS Code 5411.

Lineage Cell Therapeutics is a publicly traded company on ASE using the ticker symbol BTX$. Detailed information on company financials and operating reports can be found here: ASE: BTX$

Lineage Cell Therapeutics Annual Revenue and Growth Rate

Lineage Cell Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Lineage Cell Therapeutics's revenues are gauged from an analysis of company filings.

Investor Activity

Lineage Cell Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
March 7, 2014	3	23%	$15 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Lineage Cell Therapeutics is developing and marketing. Lineage Cell Therapeutics doesn't have any recent trademark applications, indicating Lineage Cell Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
LINEAGE CELL THERAPEUTICS Pharmaceutical preparations and compositions for therapeutic use and treatment in the areas of ophthalmology, neurological conditions, oncology, neurotology; pharmaceutical preparations and compositions for cell therapy treatment and transplant medicine	02/14/2023
RESONANCE Pharmaceutical preparations and therapeutic biological products in the nature of living cells for use in treating hearing/auditory conditions and disorders; pharmaceutical preparations and therapeutic biological products in the nature of living cells for use in treating conductive hearing loss, sensorineural hearing loss, central hearing loss, mixed hearing loss, auditory neuropathy spectrum disorder and central auditory processing disorder and other hearing/auditory conditions and disorders	03/31/2022
LINEAGE CELL Pharmaceutical and biological research and development services in the field of cellular therapies, cell-based tissue regeneration and engineering, extracellular matrix biomaterial, cellular repair technology, cellular replacement therapy, cellular restoration therapy, cellular therapy delivery technology and cell culturing; Providing medical research information in the field of cellular therapies, cell-based tissue regeneration and engineering, extracellular matrix biomaterial, cellular repair technology, cellular replacement therapy, cellular restoration therapy, cellular therapy delivery technology and cell culturing	04/13/2021

See all trademarks and details in the Full Report.

Market Share of Lineage Cell Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Lineage Cell Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AUSTIN 316 FIDUCIARY LIMITED	Oceanside, NY	100
CONSILIO	Washington, DC	66
LATHAM & WATKINS	Los Angeles, CA	54
KIRKLAND & ELLIS	Chicago, IL	49
CO STATE FRATERNAL ORDER OF POLICE	Westminster, CO	44
GREENBERG TRAURIG P.A.	Miami, FL	42
PROFESSIONAL LAW ENFORCEMENT A	Rochester, MI	38
CHG COMPANIES	Midvale, UT	35
BAKER & MCKENZIE	Chicago, IL	33

Nearby Competitors

These companies are similar in business line and location to Lineage Cell Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
TYSON & MENDES	La Jolla, CA	100
HARRIS PERSONAL INJURY LAWYERS	Oceanside, CA	20
LORBER GREENFIELD & POLITO	Poway, CA	14
REESE LAW GROUP APLC	Carlsbad, CA	13
DALEY & HEFT	Solana Beach, CA	11
WINET PATRICK GAYER CREIGHTON & HANES	Vista, CA	9

Future Competition: Lineage Cell Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Lineage Cell Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)